JSM Activity #131

Back to main JSM 2001 Program page


Activity ID:  131
Title Room
* Novel Analysis for Clinical Trials H-Newton
Date / Time Sponsor Type
08/06/2001    2:00 PM  -  3:50 PM Biopharmaceutical Section*, ENAR Contributed
Organizer: n/a
Chair: Brian Wiens, Amgen, Inc.
Discussant:  
  300921  By:  Kun Jin 2:05 PM 08/06/2001
Blind Analysis and Possible Bias

  300716  By:  Lu Cui 2:20 PM 08/06/2001
Issues Related to Subgroup Analysis

  300994  By:  Keaven  Anderson 2:35 PM 08/06/2001
A Flexible Spending Function for Interim Analysis Design

  300728  By:  Michele Shaffer 2:50 PM 08/06/2001
Supplementing the Intent-to-treat Analysis: Accounting for Treatment Failures in Clinical Trials

  300624  By:  Jared Lunceford 3:05 PM 08/06/2001
Estimation of Survival Distributions of Treatment Policies in Two-stage Randomization Designs in Clinical Trials

  300902  By:  Leslie McClure 3:20 PM 08/06/2001
Multiple Outcomes in Clinical Trials: A Comparison of Methods

  301218  By:  Yong Wang 3:35 PM 08/06/2001
Assessing Clinical Treatment Effects of Bio-Drug by Using Immune Responses of Change in Lymphocytes and Lymphocyte Sub-populations

JSM 2001

For information, contact meetings@amstat.org or phone (703) 684-1221.

If you have questions about the Continuing Education program, please contact the Education Department.

Revised March 2001